Sr. Policy Analyst, Office Of Regulatory Programs, Cdrh, Fda
CurrentResponsible for policy development related to varied program activities within ORP. Main areas of focus include postmarket surveillance, adverse event terminology, Unique Device Identification (UDI) and communications.